Thiogenesis Therapeutics Corp (TSE:TTI)
TSXV:TTI
Canadian Market

Thiogenesis Therapeutics Corp (TTI) Financial Statements

1 Followers

Thiogenesis Therapeutics Corp Financial Overview

Thiogenesis Therapeutics Corp's market cap is currently ―. The company's EPS TTM is C$-0.115; its P/E ratio is -5.63; Thiogenesis Therapeutics Corp is scheduled to report earnings on August 21, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.05M$ -870.39K$ -1.07M$ 78.47K$ -1.23M
EBITDA$ -1.05M$ -870.39K$ -1.07M$ 78.47K$ -1.23M
Net Income Common Stockholders$ -1.05M$ -870.39K$ -1.07M$ 79.18K$ -1.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.63M$ 4.64M$ 5.32M$ 6.20M$ 1.61M
Total Assets$ 3.69M$ 4.70M$ 5.35M$ 6.29M$ 1.64M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -3.63M$ -4.64M$ -5.32M$ -6.20M$ -1.61M
Total Liabilities$ 320.44K$ 349.83K$ 258.00K$ 307.15K$ 80.93K
Stockholders Equity$ 3.37M$ 4.35M$ 5.09M$ 5.98M$ 1.55M
Cash Flow-
Free Cash Flow$ -991.64K$ -685.15K$ -875.06K$ -282.66K$ -594.05K
Operating Cash Flow$ -991.64K$ -685.15K$ -875.06K$ -282.66K$ -594.05K
Investing Cash Flow---$ -3.24M-
Financing Cash Flow---$ 8.21M$ 3.67K
Currency in USD

Thiogenesis Therapeutics Corp Earnings and Revenue History

Thiogenesis Therapeutics Corp Debt to Assets

Thiogenesis Therapeutics Corp Cash Flow

Thiogenesis Therapeutics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis